Overview Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease Status: Completed Trial end date: 2007-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to compare the clinical efficacy of IPX054 to immediate-release carbidopa-levodopa in subjects with Parkinson's disease. Phase: Phase 2 Details Lead Sponsor: IMPAX Laboratories, Inc.Impax Laboratories, LLCTreatments: CarbidopaCarbidopa, levodopa drug combinationLevodopa